![Gold prices creep higher; strong dollar, inflation jitters weigh](https://i-invdn-com.investing.com/news/LYNXNPEC4I0Z1_S.jpg)
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.07 | 2.72 | 0.65 |
Stocks | 97.92 | 97.92 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 23.97 | 20.52 |
Price to Book | 5.01 | 4.45 |
Price to Sales | 2.52 | 2.44 |
Price to Cash Flow | 22.04 | 17.32 |
Dividend Yield | 0.85 | 1.11 |
5 Years Earnings Growth | 12.52 | 11.01 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.25 | 99.53 |
Basic Materials | 0.75 | 0.54 |
Number of long holdings: 54
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 12.90 | 885.50 | +0.18% | |
Merck&Co | US58933Y1055 | 8.31 | 131.18 | +0.35% | |
Vertex | US92532F1003 | 4.84 | 472.00 | +0.70% | |
UnitedHealth | US91324P1021 | 4.59 | 485.57 | +0.62% | |
Amgen | US0311621009 | 4.43 | 310.32 | +0.70% | |
Novo Nordisk ADR | US6701002056 | 4.21 | 142.07 | +0.08% | |
Humana | US4448591028 | 3.91 | 354.81 | -0.19% | |
Boston Scientific | US1011371077 | 3.50 | 77.39 | -0.42% | |
AstraZeneca ADR | US0463531089 | 3.31 | 79.22 | +0.43% | |
Regeneron Pharma | US75886F1075 | 3.22 | 1,058.62 | +0.52% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Prudential Jennison Growth Z | 4.33B | 13.42 | 7.26 | 15.53 | ||
Prudential Jennison Global Opps Z | 3.22B | 15.17 | 3.38 | 14.12 | ||
Prudential Jennison Utility A | 2.51B | 16.53 | 7.45 | 7.64 | ||
Prudential Jennison Small Company Q | 2.06B | 3.39 | 1.04 | 9.59 | ||
Prudential Jennison Growth A | 1.98B | 13.27 | 6.93 | 15.18 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review